A Study to Evaluate the Safety and Efficacy of RQC for AMD
NCT05062486
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Age-related Macular Degeneration
Interventions
DRUG:
Resveratrol, Quercetin, Curcumin (RQC)
DRUG:
Curcumin
Sponsor
Paul A Knepper, MD PhD